Advertisement
Home 2015

Archives

More than half of U.S. states are poorly prepared to respond to infectious disease outbreaks

Over Half of U.S. States Ill Prepared for Disease Outbreaks

0
Efforts needed to boost ability to respond to viruses, superbug threats
The Fenix Continence Restoration System has been approved by the U.S. Food and Drug Administration to treat an inability to control bowel movements for patients who can't tolerate or use other approved methods.

FDA Approves New Device for Fecal Incontinence

0
Viable surgical option when medical measures have failed
The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

FDA Approves LifeVest Wearable Defibrillator for Children

0
For heart patients who can't have device implanted
Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

FDA Approves Bridion to Reverse Neuromuscular Blockade

0
Drug reverses the effects of rocuronium bromide and vecuronium bromide
All adults and teens at increased risk for syphilis should be screened for the sexually transmitted disease

USPSTF: Screen All Teens, Adults at Risk for Syphilis

0
Proposed recommendation dovetails with surge in U.S. cases of the sexually transmitted disease
The U.S. abortion rate has declined by more than one-third over the past two decades to a record low

CDC: U.S. Abortion Rate Hits Record Low

0
In 2010, for every 100 pregnancies, 65 ended in birth, 18 in abortion, and 17 in fetal loss
Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

0
For overdose of the chemo drugs fluorouracil and capecitabine
Alecensa (alectinib) has been approved by the U.S. Food and Drug administration to treat anaplastic lymphoma kinase-positive non-small-cell lung cancer

FDA Approves Alecensa for ALK-Positive NSCLC

0
Drug is designed to block the effects of the ALK protein
The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.

FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss

0
Designed for women diagnosed with breast cancer
Fewer American families are struggling to pay medical bills

CDC: Fewer Americans Struggling With Medical Bills

0
U.S. report shows 12 million are no longer in families having trouble paying for health care